Recurrent Scrotal Hemangiomas During Treatment With Sunitinib
Author:
Affiliation:
1. Campus Bio-Medico University of Rome, Rome, Italy
Publisher
American Society of Clinical Oncology (ASCO)
Subject
Cancer Research,Oncology
Link
http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2010.30.4865
Reference8 articles.
1. Dermatological reactions to the multitargeted tyrosine kinase inhibitor sunitinib
2. Surrogate biomarkers in evaluating response to anti-angiogenic agents: focus on sunitinib
3. Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor
4. Endothelial Progenitor Cells Isolation and Characterization
5. Pathogenesis of infantile haemangioma: new molecular and cellular insights
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Case Report: Targeted Therapy for Metastatic Solid Pseudopapillary Neoplasm of the Pancreas With CTNNB1 and PTEN Mutations;Frontiers in Oncology;2021-10-18
2. Zebrafish Cancer Predisposition Models;Frontiers in Cell and Developmental Biology;2021-04-27
3. A Case Report of Multiple Capillary Hemangioma in a Chronic Myeloid Leukemia Patient Taking Tyrosine Kinase Inhibitors;Annals of Dermatology;2021
4. Cutaneous Adverse Effects Associated With the Tyrosine-Kinase Inhibitor Cabozantinib;JAMA Dermatology;2015-02-01
5. Fármacos antiangiogénicos y piel: efectos cutáneos adversos de sorafenib, sunitinib y bevacizumab;Actas Dermo-Sifiliográficas;2014-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3